EDN1 and prostate carcinoma: In turn, Weydert et al. (2009) demonstrated increased secretion of endothelin-1 in prostate cancer cell lines (PC-3 and 22Rv1), and emphasized the importance of its local concentration and its impact on tumor growth, especially metastatic.